Literature DB >> 9136873

Identification of a loop outside the active site cavity of the human immunodeficiency virus proteases which confers inhibitor specificity.

E M Towler1, S K Thompson, T Tomaszek, C Debouck.   

Abstract

We have investigated the inhibitor specificity for the proteases of the human immunodeficiency viruses, types 1 and 2. Using a series of related inhibitors, the P1' side chain was confirmed to play a significant role in determining both the absolute and relative affinity for the enzymes. To further define the residues in the enzymes responsible for the difference in affinity, chimeric proteins were constructed in which domains of the respective proteases were exchanged at the genetic level. The results of these studies demonstrated that inhibitor affinity is conferred by a combination of the active site residues (32, 47, and 82) along with a loop comprised of residues 31 and 33-37, which lies outside of the active site cavity. These results are discussed in terms of existing structural data.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136873     DOI: 10.1021/bi962729j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease.

Authors:  Deborah S Dauber; Rainer Ziermann; Neil Parkin; Dustin J Maly; Sami Mahrus; Jennifer L Harris; Jon A Ellman; Christos Petropoulos; Charles S Craik
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.

Authors:  Y C Lin; Z Beck; T Lee; V D Le; G M Morris; A J Olson; C H Wong; J H Elder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.

Authors:  L Hong; X C Zhang; J A Hartsuck; J Tang
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

4.  Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107.

Authors:  Ramachandran Murali; Xin Cheng; Alan Berezov; Xiulian Du; Arnie Schön; Ernesto Freire; Xiaowei Xu; Youhai H Chen; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.